Psychiatry Research: Neuroimaging
Volume 181, Issue 1 , Pages 77-84 , 30 January 2010

Gender, personality, and serotonin-2A receptor binding in healthy subjects

  • Paul H. Soloff

      Affiliations

    • Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • PET Center, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • Corresponding Author InformationCorresponding author. Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, PA 15213, United States.
    • ,
  • Julie C. Price

      Affiliations

    • Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • PET Center, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Neale Scott Mason

      Affiliations

    • Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • PET Center, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Carl Becker

      Affiliations

    • Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • PET Center, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Carolyn C. Meltzer

      Affiliations

    • Department of Radiology, Emory University School of Medicine, Atlanta, GA, United States

Received 18 August 2008 ,Revised 27 July 2009 ,Accepted 28 August 2009.

References 

  1. Adams K, Pinborg LH, Svarer C, Hasselbalch SG, Holm S, Haugbol S, et al. A database of [18F]-altanserin binding to 5HT2a receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage. 2004;21:1105–1113
  2. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre-and post synaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research. 1995;688:121–133
  3. Arango V, Underwood MD, Mann JJ. Postmortem findings in suicide victims. Implications for in vivo studies. Annals of the New York Academy of Science. 1997;836:269–287
  4. Arato M, Frecska E, Tekes K, MacCrimmon DJ. Serotonergic interhemispheric asymmetry: gender difference in the orbital cortex. Acta Psychiatrica Scandinavica. 1991;84:110–111
  5. Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, van Heeringen C, et al. Decreased frontal serotonin 5HT2a receptor binding index in deliberate self-harm patients. European Journal of Nuclear Medicine. 2001;28(2):175–182
  6. Baeken C, D'haenen H, Flamen P, Mertens J, Terriere D, Chavatte K, et al. 123I-5-I-R91150, a new single photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects. European Journal of Nuclear Medicine. 1998;25:1617–1622
  7. Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, et al. Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology. 2004;29:1143–1155
  8. Barratt ES, Slaughter L. Defining, measuring and predicting impulsive-aggression: a heuristic model. Behavioral Sciences and the Law. 1998;16:285–302
  9. Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby P. Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11 C] MDL 100, 907. American Journal of Psychiatry. 2006;163:1580–1587
  10. Biver F, Lotstra F, Monclus M, Wikler D, Damhaut P, Mendlewicz J, et al. Sex difference in 5-HT2 receptor in the living human brain. Neuroscience Letters. 1996;204(1–2):25–28
  11. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. British Journal of Psychiatry. 1997;171:444–448
  12. Brown GL, Goodwin FK. Cerebrospinal fluid correlates of suicide attempts and aggression. Annals of the New york Academy of Science. 1986;487:175–188
  13. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. Journal of Consulting and Clinical Psychology. 1959;21:343–349
  14. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The Temperament and Character Inventory (TCI): a Guide to Its Development and Use. Washington University, St. Louis, MO: Center for Psychobiology of Personality; 1994;1994
  15. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd Edition. Hillsdale, NJ.: Lawrence Erlbaum Associates; 1988;
  16. Cohen J. A power primer. Psychological Bulletin. 1992;112:155–159
  17. Dillon K, Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain post-mortem: effects of age and alcohol. Brain Research. 1991;554:56–64
  18. Dwivedi Y, Pandey GN. Quantitation of 5HT2a receptor mRNA in human postmortem brain using competitive RT-PCR. Neuroreport. 1998;9:3761–3765
  19. Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, McConaha C, et al. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biological Psychiatry. 2002;52:896–906
  20. Frokjaer VG, Mortensen EL, Nielsen FA, Haugbol S, Pinborg LH, Adams KH, et al. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological Psychiatry. 2008;63:569–576
  21. Guy, W., 1976. ECDEU Assessment Manual of Psychopharmacology—Revised. DHEW Publ. No. ADM 76-338. Superintendent of Documents, U.S. Government Printing Office, Washington, DC.
  22. Halbreich U, Rojansky N, Zander KJ, Barkai A. Influence of age, sex, and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. Journal of Psychiatric Research. 1991;25:7–18
  23. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gunn RN, Holden J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. Journal of Cerebral Blood Flow and Metabolism. 2007;27:1533–1539
  24. Kaye WH, Frank GK, Meltzer CC, Price JC, McConaha C, Crossan PJ, et al. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. American Journal of Psychiatry. 2001;158:1152–1155
  25. Klompenhouwer J-L, Fekkes D, van Hulst AM, Moleman P, Pepplinkhuizen L, Mulder PGH. Seasonal variations in binding of 3H-paroxetine to blood platelets in healthy volunteers: indications for a gender difference. Biological Psychiatry. 1990;28:509–517
  26. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153–158
  27. Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L. Fluorine-18-altanserine: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. Journal of Nuclear Medicine. 1991;32:2266–2272
  28. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time–activity measurements applied to [N-11C-methyl]-(−)-cocaine PET studies in human subjects. Journal of Cerebral Blood Flow and Metabolism. 1990;10:740–747
  29. Loranger AW, Susman VL, Oldham JM, Russakoff LM. The personality disorder examination: a preliminary report. Journal of Personality Disorders. 1987;1:1–3
  30. Marazziti D, Rossi A, Palego L, Barsanti A, Carrai M, Giannaccini G, et al. Effect of aging and sex on the [3H]-paroxetine binding to human platelets. Journal of Affective Disorders. 1998;50:11–15
  31. Matsubara S, Arora H, Meltzer H. Serotonergic measures in suicide brain: 5HT1A binding sites in frontal cortex of suicide victims. Journal of Neural Transmission. 1991;85:181–194
  32. McBride PA, Tierney H, DeMeo M, Chen J-S, Mann JJ. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biological Psychiatry. 1990;27:1143–1155
  33. Meltzer CC, Drevets WC, Price JC, Mathis CA, Lopresti B, Villemagne VL, et al. Gender-specific aging effects on the serotonin 1A receptor. Brain Research. 2001;895:9–17
  34. Meltzer CC, Kinahan PE, Greer PJ, Nichols TE, Comtat C, Cantwell MN, et al. Comparative evaluation of MR-based partial volume correction schemes for PET. Journal of Nuclear Medicine. 1999;40:2053–2065
  35. Meltzer CC, Smith G, Price JC, Reynolds CF, Mathis CA, Greer P, et al. Reduced binding of [18F] altanserin to serotonin type 2A receptors in aging: persistance of effect after partial volume correction. Brain Research. 1998;813:167–171
  36. Messa C, Colombo C, Moresco RM, Gobbo C, Galli L, Lucignanbi G, et al. 5-HT2A receptor binding is reduced in drug-naïve and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology. 2003;167:72–78
  37. Meyer JH, McMain S, Kennedy SH, Korman L, Brown G, DaSilva JN, et al. Dysfunctional attitudes and 5HT2 receptors during depression and self-harm. American Journal of Psychiatry. 2003;160:90–99
  38. Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F] altanserin positron emission tomography. Biological Psychiatry. 2004;55:217–224
  39. Moresco FM, Dieci M, Vita A, Messa C, Gobbo C, Galli L, et al. In vivo serotonin 5HT2A receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage. 2002;17:1470–1478
  40. Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN, Butters MA, et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biological Psychiatry. 2000;48:854–860
  41. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V, et al. Blunted prefrontal cortical 18Fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Archives of General Psychiatry. 2002;59:621–629
  42. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences USA. 1997;94:5308–5313
  43. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatric Clinics of North America. 2000;23(1):11–27
  44. Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V, et al. Effects of age, sex, and aggressive traits in man on brain serotonin 5-HT(1A) receptor ligand binding potential measured by PET using [C-11] WAY-100635. Brain Research. 2002;954(2):173–182
  45. Price JC, Lopresti BJ, Mason NS, Holt DP, Huang Y, Mathis CA. Analyses of [18F] altanserin bolus injection PET data. II. Consideration of radiolabeled metabolites in baboons. Synapse. 2001;41:1–10
  46. Price JC, Lopresti BJ, Meltzer CC, Smith G, Mason NS, Huang Y, et al. Analyses of [18F] altanserin bolus injection PET data. II. Consideration of radiolabeled metabolites in humans. Synapse. 2001;41:11–21
  47. Rosel P, Arranz B, Vallejo J, Oros M, Crespo JM, Menchon JM, et al. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains. Psychiatry Research. 1998;82:161–170
  48. Rosel P, Arranz B, San L, Vallejo J, Crespo JM, Urretavizcaya M, et al. Altered 5-HT(2A) binding sites and second messenger inositol triphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicides. Psychiatry Research. 2000;99:173–181
  49. Smith GS, Price JC, Lopresti B, Huang Y, Simpson N, Holt D. Test re-test variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse. 1998;30:380–392
  50. Soloff PH, Meltzer CC, Becker C, Greer PJ, Constantine D. Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder. Psychiatry Research: Neuroimaging. 2005;138:183–195
  51. Soloff PH, Price JC, Meltzer CC, Fabio A, Frank GK, Kaye WH. 5HT2A receptor binding is increased in borderline personality disorder. Biological Psychiatry. 2007;62:580–587
  52. Spitzer RL, Williams JBW, Gibbon M, First MB. Instruction Manual for the Structured Clinical Interview for DSMIII-R. 722 West 168th Street, NY, NY: Biometrics Research Department, New York State Psychiatric Inst.; 1988;
  53. Staley JK, Van Dyck CH, Tan PZ, Al Tikriti M, Ramsby Q, Klump H, et al. Comparison of [18F] altanserin and [18F] deuteroaltanserin for PET imaging of serotonin 2A receptors in baboon brain: pharmacologic studies. Nuclear Medicine and Biology. 2001;28:271–279
  54. Van Heeringen C, Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, et al. Prefrontal 5-HT2A receptor binding index, hopelessness and personality characteristics in attempted suicide. Journal of Affective Disorders. 2003;74:149–158
  55. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. Journal of Computer Assisted Tomography. 1993;17:536–546
  56. Yatham LN, Liddle PF, Shiah I-Shin, Scarrow G, Lam R, Adam MJ, et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Archives of General Psychiatry. 2000;57:850–858
  57. Zhang L, Ma W, Barker JL, Rubinow DR. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience. 1999;94:251–259

PII: S0925-4927(09)00195-4

doi: 10.1016/j.pscychresns.2009.08.007

Psychiatry Research: Neuroimaging
Volume 181, Issue 1 , Pages 77-84 , 30 January 2010

Article Tools

* Image Usage & Resolution